Upgrades

  • Southern Company (SO) upgraded by KeyBanc from Underweight to Sector Weight
  • Danone (DANOY) upgraded by BNP Paribas from Neutral to Outperform
  • Nexans (NXPRF) upgraded by Barclays from Equal Weight to Overweight
  • Dow Inc. (DOW) upgraded by KeyBanc from Sector Weight to Overweight
  • LyondellBasell (LYB) upgraded by KeyBanc from Sector Weight to Overweight
  • RPM (RPM) upgraded by Baird from Neutral to Outperform
  • Target (TGT) upgraded by Bernstein from Underperform to Market Perform
  • Target (TGT) upgraded by Telsey Advisory from Market Perform to Outperform
  • Ross Stores (ROST) upgraded by Telsey Advisory from Market Perform to Outperform
  • Intellia Therapeutics (NTLA) upgraded by JonesResearch from Hold to Buy
  • Tesla (TSLA) upgraded by BofA from Neutral to Buy
Put $1,000 into this stock now [Not NVDA] [sponsor]
The legendary stockpicker who built one of Wall Street's most popular buying indicators just announced the #1 stock to buy for 2026. His last recommendations shot up 100% and 160%. Now for a limited time, he's sharing this new recommendation live on-camera, completely free of charge. It's not NVDA, AMZN, TSLA, or any stock you'd likely recognize. Click here for the name and ticker.

Downgrades

  • Great Elm Capital (GECC) downgraded by Clear Street from Buy to Hold
  • Dassault Systemes (DASTY) downgraded by Goldman Sachs from Buy to Neutral
  • Select Medical (SEM) downgraded by Deutsche Bank from Buy to Hold
  • LegalZoom (LZ) downgraded by Barclays from Equal Weight to Underweight
  • GitLab (GTLB) downgraded by Piper Sandler from Overweight to Neutral
  • Avient (AVNT) downgraded by KeyBanc from Overweight to Sector Weight
  • Alpha Tau (DRTS) downgraded by Piper Sandler from Overweight to Neutral
  • Cooper Companies (COO) downgraded by Rothschild & Co Redburn from Buy to Neutral
  • Theravance Biopharma (TBPH) downgraded by B. Riley from Buy to Neutral
  • Vulcan Materials (VMC) downgraded by JPMorgan from Overweight to Neutral
  • Kuehne & Nagel (KHNGY) downgraded by HSBC from Hold to Reduce
  • Select Medical (SEM) downgraded by Benchmark from Buy to Hold
History-Making Stocks Rarely Make Headlines. [sponsor]
While Nvidia makes all the headlines, this little-known company is already beginning to surpass Nvidia's stock gains this year as data center growth surges. I believe this stock could soar in the next 12-24 months, potentially leaving Nvidia in the dust. I want to give you the name, ticker and my full analysis today – because I know you certainly won't hear about this stock in the mainstream financial media. Click here to get all the details...

fly360

Upgrades & Downgrades provided by The Fly at http://www.thefly.com.  The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.